Name: UMIN ID:
Unique ID issued by UMIN | UMIN000035974 |
---|---|
Receipt number | R000040882 |
Scientific Title | RETROSPECTIVE JAPANESE REAL WORLD STUDY OF METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB PLUS IPILIMUMAB (J-cardinal study) |
Date of disclosure of the study information | 2019/02/22 |
Last modified on | 2022/09/01 14:20:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/02/22 13:00:34 | ||
2 | Update | 2019/02/22 13:03:56 | Public title Public title |
|
3 | Update | 2019/03/01 11:52:26 | Condition Condition |
|
4 | Update | 2020/02/04 08:32:19 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name Zip code TEL Last name of contact person Last name of contact person Zip code TEL Name of person sending information Name of person sending information Division name Division name Email1 Organization Organization Address Address Tel |
|
5 | Update | 2020/02/04 08:35:46 | Email |
|
6 | Update | 2020/08/24 10:17:10 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2020/08/24 10:18:35 | Number of participants that the trial has enrolled |
|
8 | Update | 2021/02/26 16:03:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Name of person sending information Name of person sending information Division name Address Address TEL Organization1 Email1 Organization Organization |
|
9 | Update | 2022/09/01 13:57:01 | Recruitment status |
|
10 | Update | 2022/09/01 14:20:51 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |